The AcrySof IQ PanOptix® Trifocal IOL is the first and only FDA-approved trifocal lens implant. The range of vision delivered by the PanOptix trifocal lens offers a considerable reduction in a patient’s need for glasses after cataract surgery. This lens technology allows a patient to be able to see their cell phone, computer, and golf ball without glasses.
The technology of the PanOptix lens offers patients the broadest range of vision all in one lens as compared to any other cataract lens implant in the US. The PanOptix® trifocal lens was developed using ENLIGHTEN® Optical Technology, which optimizes intermediate vision without compromising the quality of near and distance vision. In addition, the PanOptix® lens is designed to help patients who have astigmatism, as well as those who do not.
Before the PanOptix lens was FDA approved in the US, it was the leading lens technology offered to cataract patients in more than 70 countries. The Cleveland Eye Clinic surgeons were the first in Ohio to implant a PanOptix Trifocal IOL.
Based on the FDA study, over 99% of patients who receive the PanOptix® lens would choose the same lens again. This level of patient satisfaction with the PanOptix® lens illustrates the value this technology has brought.
The Cleveland Eye Clinic surgeons are committed to offering the latest innovations in cataract surgery to each of our patients. Our goal is to offer our patients the best technology options, and a warm comfortable experience. The PanOptix® lens is another innovative lens option that will be an excellent option for many of our patients.